FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1854715522> ?p ?o ?g. }

• W1854715522 endingPage "800" @default.
• W1854715522 startingPage "791" @default.
• W1854715522 abstract "To evaluate the in vitro spectrum and activity of linezolid, a recent oxazolidinone, according to well-controlled surveillance data from 42 medical centers in 13 countries throughout Europe.Participants tested the susceptibility of 125 clinical strains of enterococcal and staphylococcal species against 13 drugs using reference broth microdilution trays or the standardized disk diffusion method of the National Committee for Clinical Laboratory Standards (NCCLS). Streptococcal species (n = 25 at each center) were tested against six drugs using E test (AB BIODISK, Solna, Sweden). Quality assurance testing was conducted using NCCLS-recommended strains and verification of resistance to linezolid and other selected agents was performed by retesting strains at the regional (Europe) and international (USA) monitor sites.A total of 5598 strains from throughout Europe (91% compliance) were tested. Vancomycin resistance was reported in only 0.6 and 3.0% of Enterococcus faecalis and E. faecium, respectively. Penicillin resistance occurred in 25.1% of Streptococcus pneumoniae; 4.9% at the high-level (> or =2 mg/L). The MIC90 for linezolid was 1 mg/L for streptococci and 2 mg/L for enterococci and staphylococci. Using the US FDA- and EUCAST-recommended susceptible breakpoints for linezolid, there were no confirmed reports of linezolid resistance [minimum inhibitory concentration (MIC), > or =8 mg/L]. The distribution of linezolid MIC values was unimodal and varied between 0.25 and 1 mg/L for streptococci (>90% of isolates), and between 1 and 2 mg/L for staphylococci (>90%) and enterococci (>95%). There were no differences in linezolid susceptibility in the vancomycin-, oxacillin-, or penicillin-resistant subsets of strains when compared to susceptible organism populations.Compared to the North American component of this study, there was substantially less vancomycin resistance among E. faecium isolates (Europe 3.0% vs. North America 63.4%). While the occurrence of penicillin-resistant S. pneumoniae in Europe and North America was similar (25.1% vs. 29.7%), the recovery of high-level penicillin-resistant strains was nearly three-fold higher in North America (4.9% vs. 13.2%). Only linezolid was universally active against all the tested Gram-positive isolates at </=4 mg/L." @default.
• W1854715522 created "2016-06-24" @default.
• W1854715522 creator A5030750675 @default.
• W1854715522 creator A5044679653 @default.
• W1854715522 creator A5053492923 @default.
• W1854715522 creator A5055101807 @default.
• W1854715522 creator A5091763566 @default.
• W1854715522 date "2002-12-01" @default.
• W1854715522 modified "2023-09-28" @default.
• W1854715522 title "Multicentre assessment of linezolid antimicrobial activity and spectrum in Europe: report from the Zyvox® antimicrobial potency study (ZAPS-Europe)" @default.
• W1854715522 cites W1731079655 @default.
• W1854715522 cites W1965078590 @default.
• W1854715522 cites W1988117872 @default.
• W1854715522 cites W1996727516 @default.
• W1854715522 cites W2009889907 @default.
• W1854715522 cites W2015608511 @default.
• W1854715522 cites W2027422681 @default.
• W1854715522 cites W2043178730 @default.
• W1854715522 cites W2047649930 @default.
• W1854715522 cites W2053522748 @default.
• W1854715522 cites W2053889635 @default.
• W1854715522 cites W2062879339 @default.
• W1854715522 cites W2082395198 @default.
• W1854715522 cites W2084883112 @default.
• W1854715522 cites W2092196558 @default.
• W1854715522 cites W2104312420 @default.
• W1854715522 cites W2113353811 @default.
• W1854715522 cites W2120575175 @default.
• W1854715522 cites W2130414829 @default.
• W1854715522 cites W2132319419 @default.
• W1854715522 cites W2133816029 @default.
• W1854715522 cites W2134137013 @default.
• W1854715522 cites W2141695283 @default.
• W1854715522 cites W2145525195 @default.
• W1854715522 cites W2147507520 @default.
• W1854715522 cites W2148488439 @default.
• W1854715522 cites W2151859311 @default.
• W1854715522 cites W2155315480 @default.
• W1854715522 cites W2157766752 @default.
• W1854715522 cites W2159490829 @default.
• W1854715522 cites W2162785663 @default.
• W1854715522 cites W2164297234 @default.
• W1854715522 cites W2168207172 @default.
• W1854715522 cites W2168635615 @default.
• W1854715522 cites W2336287850 @default.
• W1854715522 doi "https://doi.org/10.1046/j.1469-0691.2002.00484.x" @default.
• W1854715522 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12519352" @default.
• W1854715522 hasPublicationYear "2002" @default.
• W1854715522 type Work @default.
• W1854715522 sameAs 1854715522 @default.
• W1854715522 citedByCount "29" @default.
• W1854715522 countsByYear W18547155222012 @default.
• W1854715522 countsByYear W18547155222013 @default.
• W1854715522 countsByYear W18547155222014 @default.
• W1854715522 countsByYear W18547155222017 @default.
• W1854715522 crossrefType "journal-article" @default.
• W1854715522 hasAuthorship W1854715522A5030750675 @default.
• W1854715522 hasAuthorship W1854715522A5044679653 @default.
• W1854715522 hasAuthorship W1854715522A5053492923 @default.
• W1854715522 hasAuthorship W1854715522A5055101807 @default.
• W1854715522 hasAuthorship W1854715522A5091763566 @default.
• W1854715522 hasBestOaLocation W18547155221 @default.
• W1854715522 hasConcept C174802600 @default.
• W1854715522 hasConcept C176947019 @default.
• W1854715522 hasConcept C202751555 @default.
• W1854715522 hasConcept C2777677444 @default.
• W1854715522 hasConcept C2778980435 @default.
• W1854715522 hasConcept C2779489039 @default.
• W1854715522 hasConcept C2779895986 @default.
• W1854715522 hasConcept C2780585763 @default.
• W1854715522 hasConcept C2780950330 @default.
• W1854715522 hasConcept C2781253189 @default.
• W1854715522 hasConcept C2781414143 @default.
• W1854715522 hasConcept C4937899 @default.
• W1854715522 hasConcept C501593827 @default.
• W1854715522 hasConcept C523546767 @default.
• W1854715522 hasConcept C54355233 @default.
• W1854715522 hasConcept C55493867 @default.
• W1854715522 hasConcept C57992300 @default.
• W1854715522 hasConcept C71924100 @default.
• W1854715522 hasConcept C86803240 @default.
• W1854715522 hasConcept C89423630 @default.
• W1854715522 hasConcept C94665300 @default.
• W1854715522 hasConceptScore W1854715522C174802600 @default.
• W1854715522 hasConceptScore W1854715522C176947019 @default.
• W1854715522 hasConceptScore W1854715522C202751555 @default.
• W1854715522 hasConceptScore W1854715522C2777677444 @default.
• W1854715522 hasConceptScore W1854715522C2778980435 @default.
• W1854715522 hasConceptScore W1854715522C2779489039 @default.
• W1854715522 hasConceptScore W1854715522C2779895986 @default.
• W1854715522 hasConceptScore W1854715522C2780585763 @default.
• W1854715522 hasConceptScore W1854715522C2780950330 @default.
• W1854715522 hasConceptScore W1854715522C2781253189 @default.
• W1854715522 hasConceptScore W1854715522C2781414143 @default.
• W1854715522 hasConceptScore W1854715522C4937899 @default.
• W1854715522 hasConceptScore W1854715522C501593827 @default.
• W1854715522 hasConceptScore W1854715522C523546767 @default.
• W1854715522 hasConceptScore W1854715522C54355233 @default.

• next